EdiGene
Latest round
- Series B
Last raised
- Apr 2021
Total raised
- $165M
Investors
- 12
About EdiGene
Founded in 2015 in Beijing, China, EdiGene Inc. operates in the biotechnology sector, focusing on gene editing and cellular therapies.EdiGene Inc. specializes in advanced gene editing and cellular therapy solutions, focusing on high-throughput genomic editing, allogeneic cell therapy, and in vivo RNA base editing platforms. Their core product offerings aim to address significant healthcare challenges such as genetic diseases and cancer, providing innovative approaches to treatment. The genomic editing platform enables researchers and healthcare providers to make precise modifications to genes, facilitating potential breakthroughs in therapeutic applications.EdiGene's revenue model is structured around B2B collaborations and service agreements with research institutions and healthcare organizations. Transactions typically occur through partnerships that involve the provision of gene editing services and cellular therapies tailored to specific client needs. The company’s flagship offerings include proprietary gene editing technologies that are incorporated into client projects, with revenue generated through service fees or project-based contracts. These business interactions focus on long-term partnerships rather than direct consumer sales, ensuring that clients benefit from continuous support and access to advancements in gene therapy.EdiGene Inc. is positioned for growth through the development of upcoming products in gene editing and cellular therapies, with a focus on expanding into new markets in the Asia-Pacific region by the end of 2023.
Who invested in EdiGene
12 investors across 6 rounds
See all investors in EdiGene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EdiGene
Who invested in EdiGene?
EdiGene has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EdiGene raised?
EdiGene has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did EdiGene last raise money?
EdiGene's most recent round on record is a Series B, in Apr 2021.
What does EdiGene do?
Founded in 2015 in Beijing, China, EdiGene Inc.
Where is EdiGene headquartered?
EdiGene is headquartered in Beijing, China.
Which VCs invest in companies like EdiGene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at EdiGene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EdiGene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.